|
|
|
|
|
|
Theodore Friedmann, M.D. (Chairman of Recombinant DNA Advisory Committee, NIH) |
|
|
Dr. Friedmann has spent his career developing the concepts and tools of human
gene therapy. In 1972 he and one of his colleagues published a landmark paper
which proposed the use of viruses to carry normal genes into defective cells and
identified some of the medical, ethical and public policy problems posed by
modern genetic technology. He and his colleagues have made many central
technical contributions to the field of gene therapy, particularly the design
and preparation of gene transfer virus vectors and their use in disease models
to correct genetic defects in the brain and other organs. In 2002, Dr. Friedmann
had been named chair of the Recombinant DNA Advisory Committee (RAC) of the
National Institutes of Health (NIH). RAC, a 21-member committee composed of
scientists, clinical investigators, ethicists, and public policy experts, serves
a critical role in the oversight of federally funded research involving
recombinant DNA technology - the modification of organisms and tissue to express
specific genes. |
| |
|
Ansuman Chattopadhyay, Ph.D. (Head, Molecular Biology Information Service at the Health Sciences LibrarySystem, University of Pittsburgh) |
|
|
Ansuman Chattopadhyay has PhD in Biochemistry with extensive experience in
signal transduction research using molecular biology approaches. He is currently
working as Head, Molecular Biology Information Service at the Health Sciences
LibrarySystem, University of Pittsburgh, where he has developed an information
service program focused on the fields of Molecular Biology and Genetics. He
offers hands on workshops in the use of molecular biology software and
databases, provides consultation to research teams for questions related to
bioinformatics resources, developed and maintains a web-based portal for
molecular biology information. Dr. Chattopadhyay previously held positions in
the Department of Biochemistry at Vanderbilt University School of Medicine at
Nashville, TN and Cellomics Inc., at Pittsburgh, PA. |
| |
|
James Breitfeller (Retired Scientist with Eastman Kodak in their Analytical Technology Division) |
|
|
Mr. Breitfeller spent his career (25yrs) developing new analytical procedures for Surface Science, Life Science and other analytical techniques including GC, HPLC, Surface Energy and Surface Topography for the different Scientific Divisions with in Kodak. In the late 1980’s He and his colleagues developed a microorganism that produced lysine and the process was eventually sold to ADM for animal feed stock. He was one of the instrumental players in getting his division ISO-9002 certified. He holds a number of patents related to bioscience and surface chemistry. His career was cut short when he developed Melanoma in 2005. Today he authors a website for melanoma patients and oncologists a like. The research in his site that he compiles is seen in 141 countries around the world. He is in constant contact with expert oncologists and translation scientists in the melanoma field to bring the research to forefront. As a cancer patient, he was one of the first to try the Anti-CTLA-4 antibodies that was just FDA approved in March, 2011. He has a theory, that his Combinatory Therapy, acting on the T-cells has jump-started his immune system to recognize cancer. |
| |
|
Vivek Mittal, Ph.D. (Assistant Professor, Cold Spring Harbor Laboratory) |
|
|
We apply functional genomic approaches such as genome-wide transcription
profiling and RNAi- mediated gene silencing to mouse models to dissect cellular
pathways in cancer. We determine at the molecular and genetic level the
mechanisms by which endothelial cells (ECs) neovascularize a tumor to support
its continuous growth and metastasis. |
| |
|
Jake Y Chen, Ph.D. (Associate Professor at Indiana University School of Informatics and Purdue University Department of Computer and Information Science in Indianapolis (IUPUI)) |
|
| Dr. Chen is an associate professor at Indiana University School of Informatics and Purdue
University Department of Computer and Information Science in Indianapolis (IUPUI). He is the
founding director of the Indiana Center for Systems Biology and Personalized Medicine and
the Central Indiana chapter chair of the IEEE Engineering in Biology and Medicine Society. He
has been active in translational bioinformatics research and development in the past 16 years,
including six years of work experience in the biotech industry and experience in cofounding
several high-tech startup companies. His scientific expertise spans widely over biological data
management, biological data mining, bioinformatics, systems biology, and clinical applications
of genomic medicine. He has co-authored more than 90 research publication—including
three edited books, Biological Database Modeling, Biological Data Mining, and Translational
Bioinformatics (forthcoming)—and has given more than 100 invited talks worldwide. He also
helped organize over 100 Academic Biocomputing conferences, regularly served on grant
review panels for NIH, NSF, and DOE, and recently served as an information technology expert
on the National Academies’ Institute of Medicine committee on strengthening core strengths
of food and drug regulatory systems in developing countries. He holds masters and doctoral
degrees in Computer Science and Engineering from the University of Minnesota and a bachelor
degree in Biochemistry and Molecular Biology from Peking University of China. |
| |
|
|
|
|
Scientific Advisors
Our Team
Press Releases
Contact Us
|
|
|
|
|
"To run a company is not to make money. But to engage people. To make them
realize their Dream."
May 22, 1977 - Dec 14, 2010
|
|
|
Samik Singh was an entrepreneur. While he was an undergraduate student at the University of California at San Diego, he started a journal called, San Diego Biotech Journal, to promote local biotech research and companies.
He was the Founder, Publisher, and Editor of the Biotech Journal. It started as a 4-page black and white journal printed at a local Kinko’s store and became an immediate hit with local researchers.
Later he went on to publish this as a full-fledged journal and launched “Biotech Journal” website. Recent advances in science, particularly in biological sciences, fascinated him.
He had his own simple way of writing, which could be appreciated by the experts in the field as well as by laymen.
With the money saved from the advertisement revenues from the Biotech Journal, he started Protein Lounge ( proteinlounge.com) an on-line bioinformatics database with stunning graphics and animations combining with scientific accuracy to depict protein-protein interactions and relevance of proteins in various disease states.
This site is very popular with scientists and used widely across the globe.
He is no longer with us.
However, during short span of his life, he has created a unique website for the scientific community to enjoy and help in their research for years to come.
|
|